Sign up
Quantellect · Congress · Issuer Profile
NYSE: ABTAbbott Laboratories
HealthcareMkt Cap $187.95BCongress ownership rank #50

Abbott Laboratories Congressional Trading

According to U.S. congressional financial disclosures filed under the STOCK Act, members of Congress have reported 309 trades in Abbott Laboratories (NYSE: ABT) since 2012, across 70 members, worth an estimated $5.2M in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts). 168 buys against 140 sells, a modestly buy-led skew, with Democratic members responsible for 57% of the trades and Republican members 43%. The most recent disclosure shown was filed November 2026, and Rohit Khanna has filed the most ABT transactions among those shown, with 23. Other recent filers include Pete Sessions, Gilbert Cisneros, and Thomas H. Kean. One notable disclosed move was a purchase by Rohit Khanna on May 15, 2026, up 23.7% since. These figures are drawn from public House and Senate periodic transaction reports and reflect what members were required to disclose, not the current market value of any position. Abbott Laboratories's current Quantellect Tide Score is 57 out of 100 (High Tide), Top 30% of universe (3865); the Tide Score is generated algorithmically from public filings and market data and is not investment advice. For the full record, including the month-by-month buy and sell timeline, the party breakdown, top buyers and sellers, and every individual filing, see the Abbott Laboratories (ABT) stock overview and the complete trade table below.

Data updated

Trades
50
Politicians
15
Filings
31
Disclosed Vol
$877.02K
Buys
17
34%
Sells
32
64%

Price & congressional trade timeline

Party breakdown

Abbott Laboratories congressional trading activity

PoliticianPublishedTradedFiled AfterTypeSizeReturnOwner
Nov 5, 2026Oct 7, 202629 daysBuy
$1,001 - $15,000
+5.82%Spouse
Oct 27, 2026Oct 2, 202625 daysSell
$50,001 - $100,000
+7.16%Spouse
Oct 12, 2026Sep 18, 202624 daysBuy
$1,001 - $15,000
+1.82%Self
Oct 30, 2026Sep 17, 202643 daysSell
$1,001 - $15,000
+2.20%Self
Oct 7, 2026Sep 4, 202633 daysBuy
$1,001 - $15,000
-3.55%Spouse
Aug 14, 2026Jul 30, 202615 daysSell
$1,001 - $15,000
-1.07%Self
Aug 12, 2026Jul 17, 202626 daysSell
$1,001 - $15,000
+3.77%Spouse
Aug 18, 2026Jul 14, 202635 daysSell
$15,001 - $50,000
+18.28%Spouse
Jul 12, 2026Jul 8, 20264 daysSell
$1,001 - $15,000
+9.77%Self
Jul 6, 2026Jun 30, 20266 daysBuy
$1,001 - $15,000
+15.14%Spouse
Go to

Abbott Laboratories (ABT) congressional trading FAQ

Can members of Congress legally trade Abbott Laboratories (ABT) stock?

Yes. Members of Congress are permitted to trade individual stocks, including Abbott Laboratories (ABT), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; it does not imply any trade was improper.

Are congressional Abbott Laboratories (ABT) trades public?

Yes. Every congressional trade in Abbott Laboratories (ABT) on this page comes from mandatory public STOCK Act disclosure filings, which are filed with a delay and may be revised.

How many times has Congress traded Abbott Laboratories (ABT)?

Members of Congress have disclosed 309 trades in Abbott Laboratories (ABT) worth $5.2M across 70 members, according to public STOCK Act filings.

Which members of Congress have traded Abbott Laboratories (ABT)?

Recent and active filers of Abbott Laboratories (ABT) disclosures include Rohit Khanna, Gilbert Cisneros, Richard Dean Dr McCormick. The full member-by-member trade list is on this page.

Do Democrats or Republicans trade Abbott Laboratories (ABT) more?

Across disclosed Abbott Laboratories (ABT) trades, 57% were by Democrats and 43% by Republicans, led by Democrats (57%).

What is the most recent congressional Abbott Laboratories (ABT) trade?

The most recent disclosed Abbott Laboratories (ABT) filing reported a buy by Rohit Khanna, filed Nov 4, 2026.

What is Abbott Laboratories (ABT)'s Tide Score?

Abbott Laboratories (ABT) has a Quantellect Tide Score of 57 (High Tide). The Tide Score is a 0-100 read blending price forecast, smart-money flow, technicals, and social sentiment; higher is more bullish.

Browse all stocks Congress tradesCongressional trading overviewAbbott Laboratories (ABT) stock overview

Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. The Tide Score and other figures are generated algorithmically from public filings and market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.